Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

BACKGROUND: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid compared to placebo in patients with prodromal AD under the conditions applied in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mar, Javier, Gorostiza, Ania, Ibarrondo, Oliver, Larrañaga, Igor, Arrospide, Arantzazu, Martinez-Lage, Pablo, Soto-Gordoa, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731786/
https://www.ncbi.nlm.nih.gov/pubmed/33308302
http://dx.doi.org/10.1186/s13195-020-00737-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731786/
https://www.ncbi.nlm.nih.gov/pubmed/33308302
http://dx.doi.org/10.1186/s13195-020-00737-9

Ejemplares similares